skip to content

Foundation Medicine

Blog

Foundation Forward

  • June 1, 2015

    Stomaching Cancer: FoundationOne® Guides Targeted Treatment Choices and Improved Outcomes in Challenging Biliary Tract Cancers

    Imagine you or a loved one had an advanced biliary tract cancer – tumors that originate in the bile ducts or gallbladder – and you learn that all of your treatment options have been exhausted. Where do you go from there? New data presented at the 2015 ASCO Annual Meeting, including promising clinical outcomes in …

    Continue Reading

  • June 1, 2015

    Our Efforts to Advance Precision Medicine: FoundationOne® Identifies Subset of Lung Cancer Patients Likely to Respond to Targeted Therapy

    Today at ASCO, our collaborators from the University of California, Irvine presented groundbreaking new data demonstrating the role of certain genomic alterations, known as MET exon 14 (METex14), as drivers of growth of non-small cell lung cancer (NSCLC). These findings identify a unique subset of patients likely to …

    Continue Reading

  • May 31, 2015

    News from the 2015 ASCO Annual Meeting: Shouldn’t all patients with advanced cancer have access to FoundationOne® comprehensive genomic profiling?

    Of course, we say “yes!” Today at the Annual Meeting, our collaborators from the University of Texas MD Anderson Cancer Center (MDACC) and Sarah Cannon Research Institute at HealthOne, presented exciting new data demonstrating that matching patients to targeted therapies based on the unique molecular profile of the …

    Continue Reading

  • May 22, 2015

    Another important step forward for precision medicine: Palmetto GBA Publishes Final Local Coverage Determination for Comprehensive Genomic Profiling of Patients Diagnosed with Non-small Cell Lung Cancer (NSCLC)

    Following up on its earlier draft, Palmetto GBA, a Medicare administrative contractor (MAC) and thought leader in molecular diagnostics reimbursement through its innovative Molecular Diagnostics (MolDx) Program, has published a final Local Coverage Determination (LCD) outlining MolDx guidelines for coverage of …

    Continue Reading

  • May 13, 2015

    Big Strides for Little Bodies: Comprehensive Genomic Profiling with FoundationOne® Leads to Promising Outcomes in Children with Brain Cancer

    Foundation Medicine research associate, Zachary Chalmers, presented promising new data showing that the integration of comprehensive genomic profiling into clinical cancer care can lead to positive outcomes in children with brain cancer. These findings were presented in a poster entitled, “Comprehensive genomic …

    Continue Reading

  • May 7, 2015

    Foundation Medicine CEO, Michael Pellini, M.D., Featured on Precision Medicine Panel at Pershing Square Sohn Prize Award Dinner

    Foundation Medicine’s chief executive officer, Michael Pellini, M.D., will participate in a panel, “Precision Cancer Medicine: Where Are We?” at the 2015 Pershing Square Sohn Prize Award Dinner this evening, May 7, 2015. The Pershing Square Sohn Prize for Young Investigators in Cancer Research is an incredible honor …

    Continue Reading

  • April 27, 2015

    Foundation Medicine Featured in Informatics Panel at Bio-IT World

    Foundation Medicine’s vice president of knowledge informatics, Eric Neumann, Ph.D., joined a lively panel discussion titled “Accelerating Cancer Informatics at Foundation Medicine using SciDB” at last week’s Bio-IT World Expo on April 23, 2015. The panel, organized by Paradigm4, featured Paradigm4’s CEO Marilyn Matz …

    Continue Reading

  • April 17, 2015

    The Oncologist Publishes New Data from Foundation Medicine Revealing Clinically Relevant Genomic Alterations in Gastric Cancer

    A new study published in the April 16 edition of The Oncologist reveals that the majority of gastric cancers harbor at least one clinically relevant genomic alteration, demonstrating the utility of comprehensive genomic profiling to match patients to targeted therapy options and relevant clinical trials. Gastric …

    Continue Reading

  • April 16, 2015

    Recent Article Threatens to Undermine Progress in Precision Medicine

    A research article titled, “Personalized genomic analyses for cancer mutation discovery and interpretation” was published yesterday in the Science Translational Medicine. In brief, the research asserts that matched tumor and normal DNA from the same patient is necessary to prevent an unacceptably high number of false …

    Continue Reading

  • April 2, 2015

    New Data Reveal High Frequency of Clinically Relevant Genomic Alterations in Aggressive Molecular Subset of Endometrial Cancers

    A study authored by Julia Elvin, M.D., Ph.D., associate medical director & senior pathologist at Foundation Medicine, utilized FoundationOne®, a comprehensive genomic profile, to identify a high frequency of clinically relevant genomic alterations in recurrent, treatment refractory endometrioid endometrial …

    Continue Reading

Previous
  • 1
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Next

Foundation Medicine

  • Genomic Testing
  • Insights & Trials
  • Partnerships
  • About Us
  • Blog
  • Careers
  • Contact Us
  • FAQ

Genomic Testing

  • Testing Overview
  • Financial Services & Support
  • Order a Test

Insights & Trials

  • Overview
  • FoundationSmartTrials™
  • FoundationInsights™

Partnerships

  • Overview
  • Institutional Partnerships
  • Biopharma Partnerships
  • LinkedIn
  • Twitter
  • YouTube

Legal & Privacy

© 2019 Foundation Medicine, Inc. v.1.5.0